Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60


Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl.

Paccez JD, Duncan K, Sekar D, Correa RG, Wang Y, Gu X, Bashin M, Chibale K, Libermann TA, Zerbini LF.

Oncogenesis. 2019 Feb 19;8(3):14. doi: 10.1038/s41389-019-0122-6.


The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview.

Wium M, Paccez JD, Zerbini LF.

Cells. 2018 Oct 12;7(10). pii: E166. doi: 10.3390/cells7100166. Review.


The crossroads of breast cancer progression: insights into the modulation of major signaling pathways.

Velloso FJ, Bianco AF, Farias JO, Torres NE, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG.

Onco Targets Ther. 2017 Nov 20;10:5491-5524. doi: 10.2147/OTT.S142154. eCollection 2017. Review.


Potential role of P2X7R in esophageal squamous cell carcinoma proliferation.

Santos AA Jr, Cappellari AR, de Marchi FO, Gehring MP, Zaparte A, Brandão CA, Lopes TG, da Silva VD, Pinto LFR, Savio LEB, Moreira-Souza ACA, Coutinho-Silva R, Paccez JD, Zerbini LF, Morrone FB.

Purinergic Signal. 2017 Sep;13(3):279-292. doi: 10.1007/s11302-017-9559-2. Epub 2017 Apr 11.


Emerging proteomics biomarkers and prostate cancer burden in Africa.

Adeola HA, Blackburn JM, Rebbeck TR, Zerbini LF.

Oncotarget. 2017 Jun 6;8(23):37991-38007. doi: 10.18632/oncotarget.16568. Review.


Correction: Genomic Counter-Stress Changes Induced by the Relaxation Response.

Dusek JA, Otu HH, Wohlhueter AL, Bhasin M, Zerbini LF, Joseph MG, Benson H, Libermann TA.

PLoS One. 2017 Feb 21;12(2):e0172845. doi: 10.1371/journal.pone.0172845. eCollection 2017.


Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.

Adeola HA, Smith M, Kaestner L, Blackburn JM, Zerbini LF.

Oncotarget. 2016 Mar 22;7(12):13945-64. doi: 10.18632/oncotarget.7359.


GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration.

Tamura RE, Paccez JD, Duncan KC, Morale MG, Simabuco FM, Dillon S, Correa RG, Gu X, Libermann TA, Zerbini LF.

Oncotarget. 2016 Mar 22;7(12):13865-79. doi: 10.18632/oncotarget.7355.


In silico verification and parallel reaction monitoring prevalidation of potential prostate cancer biomarkers.

Adeola HA, Calder B, Soares NC, Kaestner L, Blackburn JM, Zerbini LF.

Future Oncol. 2016 Jan;12(1):43-57. doi: 10.2217/fon.15.296. Epub 2015 Nov 30.


SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1.

de Vasconcellos JF, Laranjeira AB, Leal PC, Bhasin MK, Zenatti PP, Nunes RJ, Yunes RA, Nowill AE, Libermann TA, Zerbini LF, Yunes JA.

PLoS One. 2015 Aug 24;10(8):e0134783. doi: 10.1371/journal.pone.0134783. eCollection 2015.


Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.

Beckenkamp A, Willig JB, Santana DB, Nascimento J, Paccez JD, Zerbini LF, Bruno AN, Pilger DA, Wink MR, Buffon A.

PLoS One. 2015 Jul 29;10(7):e0134305. doi: 10.1371/journal.pone.0134305. eCollection 2015.


Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multiethnic cohort of South African patients via label-free mass spectrometry.

Adeola HA, Soares NC, Paccez JD, Kaestner L, Blackburn JM, Zerbini LF.

Proteomics Clin Appl. 2015 Jun;9(5-6):597-609. doi: 10.1002/prca.201400197. Epub 2015 May 3.


Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.

Paccez JD, Duncan K, Vava A, Correa RG, Libermann TA, Parker MI, Zerbini LF.

Mol Biol Cell. 2015 Mar 1;26(5):821-31. doi: 10.1091/mbc.E14-04-0868. Epub 2015 Jan 7.


Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells.

Mello Pde A, Filippi-Chiela EC, Nascimento J, Beckenkamp A, Santana DB, Kipper F, Casali EA, Nejar Bruno A, Paccez JD, Zerbini LF, Wink MR, Lenz G, Buffon A.

Mol Biol Cell. 2014 Oct 1;25(19):2905-18. doi: 10.1091/mbc.E14-01-0042. Epub 2014 Aug 7.


Aberrant methylation of the MSH3 promoter and distal enhancer in esophageal cancer patients exposed to first-hand tobacco smoke.

Vogelsang M, Paccez JD, Schäfer G, Dzobo K, Zerbini LF, Parker MI.

J Cancer Res Clin Oncol. 2014 Nov;140(11):1825-33. doi: 10.1007/s00432-014-1736-x. Epub 2014 Jun 17.


Computational repositioning and preclinical validation of pentamidine for renal cell cancer.

Zerbini LF, Bhasin MK, de Vasconcellos JF, Paccez JD, Gu X, Kung AL, Libermann TA.

Mol Cancer Ther. 2014 Jul;13(7):1929-1941. doi: 10.1158/1535-7163.MCT-13-0750. Epub 2014 May 1.


Ectonucleotidase expression profile and activity in human cervical cancer cell lines.

Beckenkamp A, Santana DB, Bruno AN, Calil LN, Casali EA, Paccez JD, Zerbini LF, Lenz G, Wink MR, Buffon A.

Biochem Cell Biol. 2014 Apr;92(2):95-104. doi: 10.1139/bcb-2013-0051. Epub 2014 Jan 8.


Human respiratory syncytial virus N, P and M protein interactions in HEK-293T cells.

Oliveira AP, Simabuco FM, Tamura RE, Guerrero MC, Ribeiro PG, Libermann TA, Zerbini LF, Ventura AM.

Virus Res. 2013 Oct;177(1):108-12. doi: 10.1016/j.virusres.2013.07.010. Epub 2013 Jul 23.


Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer.

da Silva HB, Amaral EP, Nolasco EL, de Victo NC, Atique R, Jank CC, Anschau V, Zerbini LF, Correa RG.

Prostate Cancer. 2013;2013:920612. doi: 10.1155/2013/920612. Epub 2013 Apr 29.


The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications.

Paccez JD, Vogelsang M, Parker MI, Zerbini LF.

Int J Cancer. 2014 Mar 1;134(5):1024-33. doi: 10.1002/ijc.28246. Epub 2013 Jun 4. Review.


Targeting neddylation in cancer therapy.

Duncan K, Schäfer G, Vava A, Parker MI, Zerbini LF.

Future Oncol. 2012 Nov;8(11):1461-70. doi: 10.2217/fon.12.131. Review.


NSAIDs induce apoptosis in nonproliferating ovarian cancer cells and inhibit tumor growth in vivo.

Duncan K, Uwimpuhwe H, Czibere A, Sarkar D, Libermann TA, Fisher PB, Zerbini LF.

IUBMB Life. 2012 Jul;64(7):636-43. doi: 10.1002/iub.1035. Epub 2012 May 11.


GADD45 proteins: central players in tumorigenesis.

Tamura RE, de Vasconcellos JF, Sarkar D, Libermann TA, Fisher PB, Zerbini LF.

Curr Mol Med. 2012 Jun;12(5):634-51. Review.


The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.

Paccez JD, Vasques GJ, Correa RG, Vasconcellos JF, Duncan K, Gu X, Bhasin M, Libermann TA, Zerbini LF.

Oncogene. 2013 Feb 7;32(6):689-98. doi: 10.1038/onc.2012.89. Epub 2012 Mar 12.


Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.

Zerbini LF, Tamura RE, Correa RG, Czibere A, Cordeiro J, Bhasin M, Simabuco FM, Wang Y, Gu X, Li L, Sarkar D, Zhou JR, Fisher PB, Libermann TA.

PLoS One. 2011;6(9):e24285. doi: 10.1371/journal.pone.0024285. Epub 2011 Sep 12.


The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.

Singh R, Cadeddu RP, Fröbel J, Wilk CM, Bruns I, Zerbini LF, Prenzel T, Hartwig S, Brünnert D, Schroeder T, Lehr S, Haas R, Czibere A.

Apoptosis. 2011 Sep;16(9):889-901. doi: 10.1007/s10495-011-0624-y.


JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer.

Zerbini LF, de Vasconcellos JF, Czibere A, Wang Y, Paccez JD, Gu X, Zhou JR, Libermann TA.

Cell Cycle. 2011 Aug 1;10(15):2583-91. Epub 2011 Aug 1.


The novel compound OSI-461 induces apoptosis and growth arrest in human acute myeloid leukemia cells.

Singh R, Fröbel J, Cadeddu RP, Bruns I, Schroeder T, Brünnert D, Wilk CM, Zerbini LF, Haas R, Czibere A.

Ann Hematol. 2012 Feb;91(2):173-81. doi: 10.1007/s00277-011-1282-4. Epub 2011 Jun 30.


Structural analysis of human respiratory syncytial virus p protein: identification of intrinsically disordered domains.

Simabuco FM, Asara JM, Guerrero MC, Libermann TA, Zerbini LF, Ventura AM.

Braz J Microbiol. 2011 Jan;42(1):340-5. doi: 10.1590/S1517-83822011000100043.


Differential expression of nucleotide pyrophosphatase/phosphodiesterases by Walker 256 mammary cancer cells in solid tumors and malignant ascites.

Buffon A, Casali EA, Cardoso VV, Zerbini LF, Robson SC, Sarkis JJ, Wink MR.

Life Sci. 2010 Mar 13;86(11-12):435-40. doi: 10.1016/j.lfs.2010.01.015. Epub 2010 Feb 1.


GADD45beta enhances Col10a1 transcription via the MTK1/MKK3/6/p38 axis and activation of C/EBPbeta-TAD4 in terminally differentiating chondrocytes.

Tsuchimochi K, Otero M, Dragomir CL, Plumb DA, Zerbini LF, Libermann TA, Marcu KB, Komiya S, Ijiri K, Goldring MB.

J Biol Chem. 2010 Mar 12;285(11):8395-407. doi: 10.1074/jbc.M109.038638. Epub 2010 Jan 4.


Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.

Cho JY, Lee M, Ahn JM, Park ES, Cho JH, Lee SJ, Kim BG, Heo SH, Park HJ, Zerbini LF, Hwang D, Libermann TA.

J Proteome Res. 2009 Mar;8(3):1327-37. doi: 10.1021/pr800683b.


The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence.

Bruns I, Czibere A, Fischer JC, Roels F, Cadeddu RP, Buest S, Bruennert D, Huenerlituerkoglu AN, Stoecklein NH, Singh R, Zerbini LF, Jäger M, Kobbe G, Gattermann N, Kronenwett R, Brors B, Haas R.

Leukemia. 2009 May;23(5):892-9. doi: 10.1038/leu.2008.392. Epub 2009 Jan 22.


Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer.

Konstantinopoulos PA, Fountzilas E, Pillay K, Zerbini LF, Libermann TA, Cannistra SA, Spentzos D.

BMC Med Genomics. 2008 Nov 28;1:59. doi: 10.1186/1755-8794-1-59.


Expression and purification of a recombinant adenovirus fiber knob in a baculovirus system.

Farinha-Arcieri LE, Porchia BM, Carromeu C, Simabuco FM, Tamura RE, Ferreira LC, Zerbini LF, Ventura AM.

Intervirology. 2008;51(3):189-95. doi: 10.1159/000151532. Epub 2008 Aug 25.


Genomic counter-stress changes induced by the relaxation response.

Dusek JA, Otu HH, Wohlhueter AL, Bhasin M, Zerbini LF, Joseph MG, Benson H, Libermann TA.

PLoS One. 2008 Jul 2;3(7):e2576. doi: 10.1371/journal.pone.0002576. Erratum in: PLoS One. 2017 Feb 21;12 (2):e0172845.


Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes.

Ijiri K, Zerbini LF, Peng H, Otu HH, Tsuchimochi K, Otero M, Dragomir C, Walsh N, Bierbaum BE, Mattingly D, van Flandern G, Komiya S, Aigner T, Libermann TA, Goldring MB.

Arthritis Rheum. 2008 Jul;58(7):2075-87. doi: 10.1002/art.23504.


E-NTPDases and ecto-5'-nucleotidase expression profile in rat heart left ventricle and the extracellular nucleotide hydrolysis by their nerve terminal endings.

Rücker B, Almeida ME, Libermann TA, Zerbini LF, Wink MR, Sarkis JJ.

Life Sci. 2008 Feb 27;82(9-10):477-86. doi: 10.1016/j.lfs.2007.12.003. Epub 2008 Jan 16.


Biochemical characterization of ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP, E.C. from rat heart left ventricle.

Rücker B, Almeida ME, Libermann TA, Zerbini LF, Wink MR, Sarkis JJ.

Mol Cell Biochem. 2007 Dec;306(1-2):247-54. Epub 2007 Sep 5.


NTPDase and 5' ecto-nucleotidase expression profiles and the pattern of extracellular ATP metabolism in the Walker 256 tumor.

Buffon A, Wink MR, Ribeiro BV, Casali EA, Libermann TA, Zerbini LF, Robson SC, Sarkis JJ.

Biochim Biophys Acta. 2007 Aug;1770(8):1259-65. Epub 2007 May 21.


Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.

Gu X, Zerbini LF, Otu HH, Bhasin M, Yang Q, Joseph MG, Grall F, Onatunde T, Correa RG, Libermann TA.

Cancer Res. 2007 May 1;67(9):4219-26.


A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells.

Zerbini LF, Czibere A, Wang Y, Correa RG, Otu H, Joseph M, Takayasu Y, Silver M, Gu X, Ruchusatsawat K, Li L, Sarkar D, Zhou JR, Fisher PB, Libermann TA.

Cancer Res. 2006 Dec 15;66(24):11922-31.


Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDS.

Czibere A, Prall WC, Zerbini LF, Jäger M, Kobbe G, Knipp S, Libermann TA, Haas R, Aivado M.

Br J Haematol. 2006 Nov;135(3):355-7. Epub 2006 Sep 15.


Targeting transcription factors for cancer gene therapy.

Libermann TA, Zerbini LF.

Curr Gene Ther. 2006 Feb;6(1):17-33. Review.


Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes.

Wink MR, Braganhol E, Tamajusuku AS, Lenz G, Zerbini LF, Libermann TA, Sévigny J, Battastini AM, Robson SC.

Neuroscience. 2006;138(2):421-32. Epub 2006 Jan 18.


GADD45 deregulation in cancer: frequently methylated tumor suppressors and potential therapeutic targets.

Zerbini LF, Libermann TA.

Clin Cancer Res. 2005 Sep 15;11(18):6409-13. No abstract available.


A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation.

Ijiri K, Zerbini LF, Peng H, Correa RG, Lu B, Walsh N, Zhao Y, Taniguchi N, Huang XL, Otu H, Wang H, Wang JF, Komiya S, Ducy P, Rahman MU, Flavell RA, Gravallese EM, Oettgen P, Libermann TA, Goldring MB.

J Biol Chem. 2005 Nov 18;280(46):38544-55. Epub 2005 Sep 2.


Blockage of NF-kappaB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells.

Zerbini LF, Wang Y, Correa RG, Cho JY, Libermann TA.

Cell Cycle. 2005 Sep;4(9):1247-53. Epub 2005 Sep 24.


The nonsteroidal anti-inflammatory drug Exisulind selectively induces apoptosis via JNK in secondary acute myeloid leukemia after myelodysplastic syndrome.

Czibere A, Prall WC, Zerbini LF, Grall F, Craigie EC, Ulrich SD, Giagounidis AA, Haas R, Libermann TA, Aivado M.

Cell Cycle. 2005 Jun;4(6):812-7. Epub 2005 Jun 8.


The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes.

Grall FT, Prall WC, Wei W, Gu X, Cho JY, Choy BK, Zerbini LF, Inan MS, Goldring SR, Gravallese EM, Goldring MB, Oettgen P, Libermann TA.

FEBS J. 2005 Apr;272(7):1676-87.

Supplemental Content

Loading ...
Support Center